Results 191 to 200 of about 91,344 (325)

Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient‐centered approach that clusters two cohorts with different outcomes

International Journal of Cancer, Volume 158, Issue 3, Page 697-706, 1 February 2026.
What's new? Treatment strategies for rectal cancer are increasingly focused on organ preservation and tailored therapy. Total neoadjuvant therapy (TNT), which integrates radiotherapy and systemic chemotherapy prior to surgery, is especially promising in this regard.
Hector Guadalajara, Jose Luis Domínguez‐Tristancho, Raquel Fuentes Mateo, Miguel Leon‐Arellano, Raquel Sanz‐Baro, Eleonora Geraldi, Ana Isabel Hormigo‐Sanchez, Víctor Manuel Castellano Megías, Marta Pérez Cobos, Patricia Mellado Miras, Begoña Lopez‐Botet Zulueta, Mariano Garcia‐Arranz, Jesus García Foncillas, Cristina Caramés, Damián García‐Olmo   +14 more
wiley   +1 more source

When Carcinoembryonic Antigen Misleads: A Benign Cause of Tumor Marker Elevation. [PDF]

Cureus
Alhasan S, Alzafiri A, Tharwat H, Alhasan R, Alrashidi N.   +4 more
europepmc   +1 more source

Radiogenomics: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang, Qingpei Lai, Jin Cao, Jerry Chi Fung Ching, Xinzhi Teng, Jiang Zhang, Shara Wee Yee Lee, Ge Ren, Jing Cai   +8 more
wiley   +1 more source

Evaluation of Carcinoembryonic Antigen as a Prognostic Marker for Colorectal Cancer Relapse: Insights from Postoperative Surveillance. [PDF]

Med Sci (Basel)
Titu S, Ilies RA, Mocan T, Irimie A, Gata VA, Lisencu CI.   +5 more
europepmc   +1 more source

miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).

, 2014
Guo-Long Liu, Xia Liu, Xiaobin Lv, Xiaopai Wang, Xisheng Fang, Yi Sang   +5 more
openalex   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Carcinoembryonic Antigen [PDF]

, 2020
openaire   +1 more source

Carcinoembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium [PDF]

, 1983
Jorge Albores‐Saavedra, Mehrdad Nadji, Azorides R. Morales, Donald E. Henson   +3 more
openalex   +1 more source

Serum Carcinoembryonic Antigen Level Is Associated with Aortic Stiffness

, 2023
Abdulrahman Naser
openalex   +1 more source

Novel Drug‐Disease Modeling Framework for Oncology Benefit–Risk Evaluation: Application to Tusamitamab Ravtansine

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 2, February 2026.
ABSTRACT This study introduces a novel drug‐disease modeling framework designed to assess the benefit–risk balance of antibody‐drug conjugates (ADC) in oncology. The framework integrates dose levels, pharmacokinetics, tumor growth dynamics, progression‐free survival (PFS), and dose‐adjusted adverse events.
Marc Cerou, Christine Veyrat‐Follet, Sophie Fliscounakis‐Huynh, Clemence Pouzin, Nathalie Fagniez, Frano Mihaljevic, Mustapha Chadjaa, Emmanuelle Comets, Hoai‐Thu Thai   +8 more
wiley   +1 more source